Cavilon Advanced Skin Protectant

DEVICE4 trials

Sponsors

Solventum US LLC, Jessa Hospital

Conditions

Head and Neck CancerIncontinence Associated DermatitisIncontinence-associated DermatitisOstomyRadiation DermatitisRadiation ToxicityRadiodermatitisSkin Diseases

Unknown Phase

Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

TerminatedNCT02570139

Solventum US LLCIncontinence Associated Dermatitis

Start: 2015-10-31End: 2017-06-23Updated: 2024-10-02

Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula

TerminatedNCT03057132

Solventum US LLCOstomy

Start: 2016-11-30End: 2017-02-28Updated: 2024-12-02

Comparative Study to Assess an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis

TerminatedNCT03298113

Solventum US LLCIncontinence-associated Dermatitis

Start: 2017-11-17End: 2018-07-10Updated: 2024-12-02

A Novel Skin Barrier Protectant for Acute Radiodermatitis

WithdrawnNCT04593914

Jessa HospitalHead and Neck Cancer, Radiation Dermatitis, Radiation Toxicity +2

Start: 2020-09-01End: 2021-10-01Updated: 2021-11-03

Related Papers

Comparison of two skin protection regimes for the Prevention of Incontinence-associated Dermatitis in geriatric care (PID): a study protocol for an exploratory randomised controlled pragmatic trial

BMJ Open2022-09-014 citations